Dynavax Technologies Overview
Latest P/E ratio for Dynavax Technologies: -40.79 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-40.79
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, DVAX shows a P/E ratio of -40.79. That is below the Healthcare sector average of 26.36. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.36. Dynavax Technologies is at -40.79, which is lower that average. That is roughly 254.8% below the sector mean. Use the comparison chart on this page to see how DVAX stacks up against individual peers as well.
Investors watch DVAX's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Dynavax Technologies's latest reading is -40.79. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Dynavax Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -40.79) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.36, while DVAX is at -40.79. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
